The Biomedical Scientist Live is a new virtual event brought to you by the Institute of Biomedical Science (IBMS).
Delivered over four-days in the Autumn of 2020, The Biomedical Scientist Live will feature a Featuring a packed line up of knowledge sharing sessions, including seminars, presentations, discussions and demonstrations.
COVID-19 has brought our profession even more into the spotlight as biomedical scientists have been required to meet the challenges presented by the pandemic. The Biomedical Scientist Live will present learnings from the pandemic, share latest research across a range of specialisms, and showcase cutting-edge technologies.
The Biomedical Scientist Live event is free to access for IBMS members, If you are a non-member the fee to access the event is £150 + vat.
About the event
Please note that all sessions and timings are subject to change.
Session 1 – 16.30 – 16.55
Opening address and the IBMS during the pandemic
Allan Wilson, IBMS President.
Session 2 – 17.00 – 17.20 – Sponsored by: Beckman Coulter
Exceptional Partnership Through Exceptional Times: How cross-site connectivity can safeguard laboratory’s delivery of patient results
Ed Harris, European Clinical Informatics Marketing Manager, Beckman Coulter, Elen Banwell, Senior Biomedical Scientist (Automation?, Wrexham Maelor Hospital and Daz Yelland, Business Development Manager, Workflow & I.T. Solutions
Session 3 – 17.25 – 17.45
Leadership in Times of Crisis
Jo Horne, Consultant Healthcare Scientist, University Hospital Southampton NHS Foundation Trust.
Session 4 – 17.50 – 18.10
A Haematological Approach to Eosinophilia
Barbara Bain, Professor of Diagnostic Haematology at Imperial College London and a consultant at St Mary’s Hospital, London.
Session 5 – 18.15 – 18.35
Hair today gone tomorrow!
Guy Edward Orchard, Consultant grade Biomedical Scientist, Operations Manager, Viapath Analytics, Tissue Sciences, Guys and St. Thomas’ NHS Trust
Session 1 -16.30 – 16.55
Pathology in the time of COVID and our future
David Wells, Head of Pathology, NHS England and NHS Improvement
Session 2 – 17.00 – 17.20 – Sponsored by: Biomerieux
A year in the land of rapid syndromic pneumonia results
Phillipa Burns MSc FIBMS CSci Higher Scientific Specialist Trainee in Microbiology Hull University Teaching Hospitals
Session 3 – 17.25 – 17.45
Managing your CPD in the pandemic
Zonya D Jeffrey, Senior Biomedical Scientist – Training officer, Public Health England.
Session 4 – 17.50 – 18.10 – Sponsored by: UK NEQAS Consortium
Development and Delivery of External Quality Assessment Services During a Pandemic
Liam Whitby, President, UK NEQAS Consortium
Session 5 – 18.15 – 18.35 – Sponsored by: Ortho Clinical Diagnostics
COVID-19: Leading through the crisis
Cecilia Scarponi, EMEA Clinical Liaison, Ortho Clinical Diagnostics
Session 1 – 16.30 – 16.55
Point of Care Testing in microbiology
Sarah Pitt, Principal Lecturer, School of Pharmacy and Biomolecular Sciences, University of Brighton.
Session 2 – 17.00 – 17.20 – Sponsored by: UK NEQAS Clinical Chemistry
UK NEQAS Clinical Chemistry – getting on with helping you
Finlay MacKenzie, Consultant Clinical Scientist and Director of Birmingham Quality, UK NEQAS Clinical Chemistry External Quality Assessment Services
Session 3 – 17.25 – 17.45
Harvey’s Gang; Who, what, when, where!
Malcolm Robinson, Harvey’s Gang
Session 4 – 17.50 – 18.10
Education and the workforce of the future
Ian Davies, Biomedical Scientist and Healthcare Science Course Leader at Staffordshire University.
Session 5 -18.15 – 18.35
Wellbeing and managing workplace pressure in the pandemic
Azuma Kalu, Senior Specialist Biomedical Scientist Great Ormond Street Hospital.
Session 1 – 16.30 – 16.55
Digital pathology and working in a COVID world
Chloe Knowles, Specialist Biomedical Scientist, Leeds Teaching Hospitals NHS Trust.
Session 2 – 17.00 – 17.20
Supporting Diversity in Biomedical Science Education
Lucy Wells, Commissioning Editor for Higher Education Science, Oxford University Press
Session 3 – 17.25 – 17.45
Placement – the key to your career
Mike Carter, Scientific Education and Training Manager, Public Health England.
Session 4 – 17.50 – 18.10
Insights from the 2019 Annual SHOT Report – Focus on transfusion laboratories
Victoria Tuckley, Laboratory Incident Specialist – Serious Hazards of Transfusion, SHOT
Session 5 – 18.15 – 18.35
Barriers to CPD
Tahmina Hussain, Biomedical Scientist Team Manager & Blood Sciences Training Officer, The Christie Pathology Partnership
Please see The Biomedical Scientist Live Speaker line-up below.
Barbara previously worked as a clinical and laboratory haematologist, now concentrates on laboratory haematology, education and training of undergraduates and postgraduates (biomedical scientists and trainee haematologists), editing and publication (of textbooks and a monthly Morphology Update for the American Journal of Hematology).
Title of session: A Haematological Approach to Eosinophilia
Synopsis: The session will review the causes of eosinophilia, including eosinophilia in haematological neoplasms, and will discuss how blood film examination can contribute to elucidating the cause.
Title: A year in the land of rapid syndromic pneumonia results
Synopsis: Phillipa Burns will review pre- and post-implementation data of the rapid diagnostic BioFire pneumonia panel for patients in ITU. She will describe the current diagnostic stewardship model in place and the impact the assay has had on antimicrobial consumption and patient outcomes
Mike retired in August 2019, after 46 years in healthcare science, having worked in Liverpool, Saudi Arabia and London, being awarded ONC and HNC in biomedical sciences and a BSc and PhD in microbiology and being employed as the Scientific Education and Training Manager and Placement Programme Lead for Public Health England’s Colindale laboratories.
Mike also participated in numerous STEM activities, was a visiting lecturer for three universities and spent a three-year term as a portfolio examiner for a university.
Well, Mike almost retired, as he continues with his IBMS activities as a registration verifier, equivalence verifier, Biomedical Scientist Practitioner Representative for IBMS Degree Accreditation, a Non-accredited Degree Assessor and a Service Provider Representative on the IBMS Service User and Carer Engagement Group. He is also a member of the University of Westminster’s Employability Advisory Board, as well as undertaking other university activities.
Title of session: Placement – the key to your career
Synopsis: The PHE Colindale placement programme has welcomed through its doors 196 students representing 27 universities: 179 have completed and 15 are currently completing a one-year placement in one of its microbiology laboratories. To date, 147 placement students have had a successful verification of their Registration Training Portfolio for the IBMS Certificate of Competence (portfolio). Of the 167 who have graduated, 78 returned to work in PHE Colindale with 46 remaining and 32 moving onto diagnostic laboratories, other disciplines, research, and academia.
Although no guarantee of a permanent post following graduation can be given to placement students, they are in a very strong position should a vacancy arise in their placement laboratory or at another hospital as the experience gained on placement will open the door to opportunities the individual would otherwise not have the key to.
The presentation will guide you on where and how to look for placements, plan for and sit the interview, how to act on placement, complete the portfolio while on placement and give suggestions for what to do post-placement.
Ian is an HCPC registered Biomedical Scientist with a background in clinical practice and laboratory management within the NHS and with interests spanning the career-long education and development of biomedical scientists and in widening the input of clinical laboratories within clinical pathways and research.
Ian was awarded the Chief Scientific Officer’s Healthcare Science Award for Excellence in Education Delivery by HRH The Princess Royal for his implementation of Healthcare Science Degree Apprenticeships in 2018, and in conjunction with his colleague Katie Berger (University Hospitals of North Midlands), won the Advancing Healthcare Award for “Inspiring the Future Biomedical Science Workforce”. In 2020 Ian was listed on The Pathologist ‘Pathology Power List 2020″, a list of global innovators and leaders within pathology.
In addition to his academic role, Ian in a Fitness to Practise panel member and Education Visitor for the Health and Care Professions Council, and is a member of the Health Foundation funded Q Community.
Title: Education and the workforce of the future
Synopsis: The future of our biomedical scientist workforce is in your hands…
Over the last year we have seen the true value of biomedical science education – much more that bench skills and academic learning, education develops professionals who are resourceful, resilient and agile. That education, however, cannot happen without the input of us all – developing curricula, managing learning and development, and, most importantly, acting as role models for the future workforce.
In this talk we will explore how you, the profession, can shape and contribute to developing the future workforce. We will discover approaches to learning that put professionals at the very heart of the community of practice, and we will discuss how biomedical scientists can directly contribute to university learning, teaching and curricula.
Our future workforce will need skills and knowledge we have yet to discover, they will need to be agile and able to lead change in ways we cannot foresee, but most of all they will need you to be part of their journey.
Title: Exceptional Partnership Through Exceptional Times: How cross-site connectivity can safeguard laboratory’s delivery of patient results
Synopsis: The SARS-CoV-2 pandemic has brought unprecedented levels of uncertainty and challenges to diagnostic laboratories throughout the world. From testing challenges to trying to predict the unknown to combat the threat. From an operational perspective, laboratories have had to deal with reduce numbers of staff due to the infectious nature of the disease, or limitations due to increased restrictions to combat it.
In this session, Ed Harris, Beckman Coulter’s European Clinical Informatics Marketing Manager will be joined by Elen Banwell, Senior Biomedical Scientist (Automation) at Wrexham Maelor Hospital to discuss how her lab has overcome these challenges and ensured continuity of service to healthcare providers and their patients.
Ed will also be joined by Daz Yelland, Business Development Manager Workflow & I.T. Solutions Beckman Coulter to discuss how IT solutions can increase laboratory resilience in uncertain times.
Jo was one of the original participants in the UK national histopathology reporting diploma programme. Since then she has been working as part of the consultant specialty team at Southampton, independently dissecting and reporting gastrointestinal specimens.
Jo is a member of IBMS Council and deputy chair of the IBMS Membership & Marketing committee. She sits on conjoint boards for the histological dissection and reporting qualifications, and with the NSHCS as an examiner for the STP training programme, and as lead editor for the histopathology STP curriculum review. Jo is part of a working group reviewing Healthcare Scientist training pathways within histopathology and is passionate about their development and promotion.
Jo’s other interests include the use of media to engage, inform and promote the profession, having recently created a website for current and aspiring Healthcare Scientists. She also provides educational support, advice and mentoring support to colleagues and peers.
Title of session: Leadership in Times of Crisis
Synopsis: 2020 has been a year where leadership has been an important skill required within pathology, as well as the wider NHS and private healthcare sector. Although there have been some fantastic examples of strong leadership, there are also lessons that we can learn from the events of the last few months. This talk will focus on ways we can all show leadership within our roles, regardless of where we sit within an organisational hierarchy. We will consider examples and reflection on what went well, what we could have done better, and what we can take from 2020 to look towards a more positive future.
Tahmina started her career in 2009 as a trainee Biomedical Science student at The Christie NHS Foundation Trust. Since then, she has worked her way up to a senior level position as a Team Manager and Training Officer in Blood Sciences specialising more specifically in haematology and blood transfusion. Tahmina is an IBMS verifier and examiner for registration and specialist portfolios and has gained qualifications in both training and quality management. Tahmina is a mentor offering guidance on career pathways for third year biomedical science undergraduate students and delivers lectures for MSc haematology and transfusion science students sharing her first-hand knowledge and expertise. Tahmina is also involved in public engagement activities to promote the profession and is an IBMS CPD Officer.
Title of session: Barriers to CPD
Synopsis: The IBMS Support Hub was launched in September in order to provide support for members in professional development in biomedical science. One of the areas that members identified as challenging was maintaining CPD in the current pandemic. This session will include discussions around some of the most common barriers associated with maintaining CPD and how to break down the barriers relating to performing and documenting CPD. Some examples of CPD taken from the laboratory and work-based learning will be presented to demonstrate how CPD can be any activity from which individuals can learn, reflect and develop. Reflecting on activities and how to write up a reflective statement that details the description of an event will also be discussed. An overview of the IBMS CPD Scheme will be provided with instructions on how to log activities and gain a CPD diploma. After this session hopefully members will feel more confident and open to ideas of what CPD is and how to keep a record.
What Zonya has always enjoyed most about being a Biomedical Scientist is the various possibilities and places that our profession can take you. From training at Colindale’s reference labs and working in central London to going overseas, setting up labs in hospitals and working on tropical disease projects, such as malaria and cholera.
She is currently the Training Officer in the bacteriology department in Manchester – supporting existing colleagues and the next generation of scientists coming up into our profession.
Having been a member of the IBMS since 1996, Zonya joined the Manchester branch as CPD officer to have the opportunity to aid local members with their CPD and career development by providing advice and tips. She is excited about being able to take this work further in her new role on the IBMS national committee.
Title of session: Managing your CPD in the pandemic
Synopsis: Are you finding carrying out CPD and writing those refection statements a chore? They need not be anymore! CPD has the ability to help progress your knowledge, skills and career!
Tune in to find out the many benefits of CPD. Keep watching to see how easy it is to choose appropriate, interesting and varied activities to enhance your continued learning Learn a fun and simple way on how you can reflect on these with ease!
Azuma is a Senior Specialist Biomedical Scientist in Special Chemistry Laboratory at Great Ormond Street Hospital for Children, London. He started his career as a Biomedical Scientist in the NHS in 2004; having studied Medical Laboratory Science (First Class Honours) and completed a Masters in Medical Science degree (Distinction). Azuma has vast experience in training and mentorship at work and in his local community and shows keenness to provide pastoral care to others. His skills and experiences in managing crisis come from his own personal stories and overcoming life’s challenges. Azuma is a chartered fellow of the IBMS and currently studying for a PhD.
Title: Wellbeing and managing workplace pressure in the pandemic
Synopsis: Our physical and mental health affect our work, relationships and daily life, so it is important that both are safeguarded. Safeguarding our physical and mental health at work involves the measures we can put in place in our personal space as well those available through our employers to protect us from untoward events that could harm us physically or emotionally.
In the laboratories, we have to meet the demands of ensuring that the key performance indicators are achieved; be it meeting the turnaround times with increasing workload, reviewing quality document and performing audits in the face of staff shortage, among others. The general feeling among scientists is that there is not enough time in the day, or staff, to carry out the tasks available in the laboratories. The pressure to meet these targets are often burdensome and wear us out and could affect morale. Some of the questions we will attempt to answer through this session include: Who is responsible for our physical and mental wellbeing at work? What are common examples of activities that can cause physical and mental harm at work? What are some trigger factors? What can be done to improve physical and mental health?Wellbeing and managing workplace pressure in the pandemic
Chloe is the Specialist Biomedical Scientist for the National Pathology Imaging Co-operative, and currently leads on supporting laboratories in the West Yorkshire region to implement digital pathology, and achieve 100% slide scanning.
In 2017, Chloe started a one year Leadership and Management Fellowship in Digital Pathology where her role was to bring digital pathology into the laboratory at Leeds as part of the Leica Centre of Excellence project, where the milestone of 100% slide scanning was achieved in September 2018. Chloe also created and submitted technical evidence for ISO15189 accreditation and has published a paper with guidance for other labs that are going through the process. She has represented Biomedical Scientists at Downing Street, where she was invited to celebrate the NHS 70th Birthday, and has won awards for her work on digital pathology (NHS England Healthcare Science Rising Star Award 2018, and Advancing Healthcare Awards Rising Star Award, 2019).
Title of session: Digital Pathology vs COVID: The Ways of Remote Working
Synopsis: On Wednesday 18th March 2020, the NPIC team came into the office for the last time this year. On hearing the government’s advice that anyone who can work from should do so, the team set up in their own homes. The deployment team have planned and delivered the replacement of the existing digital pathology workflow in Leeds, and started new workflows with laboratories in the West Yorkshire region remotely, and has not been without its challenges. This session describes how the deployment of digital pathology was done during the pandemic, and highlights some of the key factors that are crucial to a successful implementation, made even more so whilst working remotely. The session will also cover the benefits of digital pathology, and how it has the potential to support remote working during the COVID-19 pandemic and the aftermath.
Finlay MacKenzie has been part of UK NEQAS since March 1987 and has been the Director of Birmingham Quality since June 2016. Finlay is a Consultant Scientist and has been a UK NEQAS Organiser since 1996. He is now the Organiser of a whole raft of Schemes broadly in the Chemistry domain.
Finlay sits on the Board of Trustees of the UK NEQAS Charity as a Clinical Chemistry nominee. He sits or has sat, on a range of IFCC Working Groups and Committees, most recently on Harmonisation of Thyroid Function Tests and the Commutability both of which have resulted in a range of publications. He has also sat on several EFLM T&F groups on Performance Limits and Total Error/Uncertainty as well as serving on the EQALM Executive Board.
One of Finlay’s passions is translating complex statistics into easy to understand, intuitive, graphic.
Guy is responsible for providing and developing the dermatopathology, Moh’s micrographic surgery and trichogram diagnostic services for the Laboratory within Viapath Analytics Tissue Sciences. He is actively involved in teaching and training, not only within Viapath and Guy’s and St. Thomas’ Trust, but also as an external lecturer at several Universities throughout the country for students studying for MSc’s in Biomedical Science. Guy sits on four editorial boards, he is the current Chief examiner for the IBMS in cellular pathology and sits on the IBMS/ Royal College of Pathologists conjoint boards for both the Higher Specialist Examination Diploma in Histological dissection and Reporting. He is the Editor of the Oxford Press books entitled Histopathology, And Cell Structure and Function, which form part of the series of books entitled Fundamentals in Biomedical Science.
Title: Hair today gone tomorrow!
Synopsis: Alopecia is a broad descriptive term describing hair loss from patchy and thinning to complete baldness. Primary alopecia is divided into two categories; scarring and non –scarring. The histopathological evaluation of scalp biopsies can be challenging for both the laboratory staff and also the reporting dermatopathologist. It often requires accurate and detailed clinical histories along with good clinical biopsy practice to ensure adequate and appropriately deep biopsies that reach the hair bulbs are performed. The subsequent histological procedures require precise and accurate slicing of the biopsies at defined depths below the dermo-epidermal junction with subsequent attention to detail whilst orientating and embedding the tissues. The process continues through the laboratory ensuring that sectioning of the embedded tissue is aligned correctly at the microtome cutting face to ensure perpendicular slicing of the embedded tissue. Multiple haematoxylin and eosin sections are performed along with defined special stains that are employed to demonstrate mucins, elastic fibres and the basement membranes of the tissues. Depending on the success of these procedures, sometimes quite subtle features can be seen and can provide evidence of the underlying causes of alopecia. Many of which will have implications for the patients concerned and their subsequent management.
Sarah is a Health and Care Professions Council (HCPC) registrant Biomedical Scientist, Fellow of the Institute of Biomedical Science (IBMS) and member of the IBMS Virology Scientific Advisory panel. She lectures in microbiology, with a particular expertise in clinical virology and parasitology. After a BSc in Microbiology from Bristol University, Sarah trained as a Biomedical Scientist at the Royal Postgraduate Medical School in London. She subsequently worked in hospital diagnostic laboratories in other parts of the UK, Africa and Central Asia. Sarah is interested in teaching and training of Biomedical Scientists and is involved in managing clinical placements in local hospital pathology departments for BSc Biomedical Science students who are looking for a career in diagnostic laboratory work.
Title of session: Point of Care Testing (POCT) in Microbiology
Synopsis: POCT offer options for rapid testing outside of the main laboratory as part of the diagnostic microbiology service. There are a range of POCT assays available. Most kits are either immunochromatographic assays (detecting either antigen or antibody) or bench top molecular analysers. They are becoming more affordable and robust enough to be used outside of main laboratories – although operators must still be fully trained and quality assurance must be maintained. In general, POCT kits in microbiology show good specificity, but sensitivity can be low compared to the standard laboratory method.
In this session, three situations where a POCT could be useful will be discussed:
The advantages and disadvantages of POCT will be outlined , with key points to consider when deciding whether to implement an assay in a particular clincial context.
Malcolm Robinson; Biomedical Scientist (retired)
Formed Harvey’s Gang in November 2014 and registered Harvey’s Gang as a Charity (1169181) in September 2016.
Title: COVID-19: Leading through the crisis:
Synopsis: Ortho Clinical Diagnostics is a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions. Ortho has been at the global forefront of research and development of infectious disease diagnostics for over 35 years protecting the blood supply and providing critical clinical diagnostic information. Leveraging upon its 35 year heritage, Ortho delivered two COVID-19 antibody tests that offer excellent clinical performance with 100% specificity, to help turn the tide on this pandemic. Join us to learn more about how Ortho is innovating to offer streamlined, sustainable COVID-19 solutions, and facilitate reliable, accurate, actionable results —even in times of crisis. Because Every Test is a Life.
Victoria Tuckley is the SHOT Laboratory Incident Specialist and is a registered Biomedical and Clinical Scientist. She has an undergraduate Masters in Biomedical Science and after successful completion of the Scientist Training Programme in 2016, has an MSc in Clinical Science (Transfusion and Haematology). Victoria has loved working within various transfusion specialties, particularly her time working within Red Cell Immunohematology, Stem Cell Immunotherapy and as a Transfusion Practitioner. She has a passion for putting the patient back at the heart of transfusion and healthcare decision making, and is delighted to be able to make a tangible improvement to patient safety through her work as part of the SHOT team.
David was recognised as being one of the 100 powerful advocates for pathology in the global community by the Pathologist magazine in 2018, 2019 and 2020. David is leading the NHS England and Improvement Pathology consolidation programme, seeking to deliver efficient, high-quality pathology services across England.
As Head of Pathology for NHS England and NHS Improvement, David has led England’s pathology services in the national response to the COVID-19 pandemic, ensuring that NHS laboratories were able to respond to the national need in standing up the required testing at pace and scale.
David is an elected IBMS council member for the London region and chair of the Membership and Marketing committee. David has also represented the IBMS on NICE diagnostic advisory panels, and various national forums, including an observer on the Royal College of Pathologist Council and in the Parliamentary and Science committee.
In October 2020 the Royal College of Pathologists awarded David Honorary Fellowship in recognition of his contribution to pathology.
Lucy Wells is the commissioning editor for higher education science at Oxford University Press. She commissions and develops print and digital resources spanning the bioscience and chemistry disciplines including biomedical science. Lucy has over ten years’ experience in science publishing and has worked on some of the leading science textbooks in the higher education sector as well as a range of specialist reference texts and practitioner handbooks.
My career has consisted of over 30 years exclusively within the NHS, initially based in general haematology, moving into flow cytometry and then into external quality assessment (EQA), where I have remained for over 20 years.
Currently I am the Director of UK NEQAS for Leucocyte Immunophenotyping and responsible for the direct delivery of EQA services to clinical flow cytometry and molecular haemato-oncology laboratories both within the UK and internationally.
I have lectured/presented at various national and international meetings (Belgium, Denmark, Greece, Hungary, Ireland, India, Italy, Japan, Kuwait, Netherlands, Norway, UK, USA) and have run flow cytometry workshops in Kuwait, South Africa, Thailand and the UK. Additionally, I am an author/co-author on over 20 scientific peer reviewed publications covering various aspects and techniques of flow cytometry and molecular genetics.
At present, I am also President of the UK NEQAS charity (Registered UK Charity No. 1044013).
Allan Wilson is the IBMS President 2020-21 and has been a council member since 2013. He started his career as a trainee in 1976 and spent more than 40 years working laboratories across the globe. He trained in Glasgow and is an expert in cytology. Today, Allan works as Lead Biomedical Scientist in Cellular Pathology and Advanced Practitioner in Cervical Cytology at Monklands Hospital, where he has been based since 1988.
Allan has also worked in senior level management for 25 years and is a cellular pathology network manager and cervical cytology consortium manager for Scotland.
He has lectured across Europe, in addition to New Zealand and Africa, which gives him a unique perspective to international laboratory practices.
Title: The Biomedical Scientist Live Launch
Synopsis: As President of the IBMS, I am delighted to launch this unique event, which will provide high-quality accessible online lectures and discussion. The pandemic has forced us to be inventive in how we deliver conferences and CPD opportunities and one of the learning outcomes from this pandemic will be how we embed on-line learning into our CPD, portfolios and academic courses.
The Biomedical Scientist Live event will provide updates on a wide range of topics and aims to plug the gap in the conference landscape by simulating real time lectures and encouraging discussion and debate about current issues.
I have never been more proud to be a Biomedical Scientist at this time, we have demonstrated the key nature of our work and the dedication that we have to deliver a vital COVID testing regime, while also delivering a “business-as-usual” routine testing service.
I have been greatly impressed by our ingenuity, inventiveness and collaboration as we seek to make COVID testing across multiple platforms “the new norm” and share best practice freely to ensure we deliver the best service for our patients.
It feels like our time has come and we have been given an opportunity to explain the vital nature of what we actually do and the dependence on high-quality testing in the fight against all disease processes. The challenge will be to ensure we do not collectively crawl back into the shadows.
Sponsorship and content/speaking opportunities are available for industry suppliers to raise their profile and share their expertise with a large audience of IBMS members and other biomedical scientists.
IBMS Company members receive a 5% discount on all packages. If you’re interested in receiving the sponsorship and content opportunities brochure please complete the below form.
The Biomedical Scientist magazine and The Biomedical Scientist Live are produced for the IBMS by Redactive.